Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel Otogenetics United States | 123 | 129 |
|
Centogene US, LLC - The Rare Disease Company United States | 203 | 194 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Corneal Dystrophies Panel Invitae United States | 65 | 33 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 288 | 218 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States | 356 | 209 |
|
PreventionGenetics United States | 2 | 1 |
|
Invitae Ectodermal Dysplasia and Related Disorders Panel Invitae United States | 148 | 73 |
|
Autosomal Dominant Hearing Loss. 25-gene NGS panel. Genologica Medica Spain | 48 | 23 |
|
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain | 146 | 94 |
|
Ectodermal dysplasia (WES based NGS panel of 42 genes, including CNV analysis) Unilabs Genetics CGC Genetics Portugal | 82 | 42 |
|
Deafness, autosomal dominant 28 (sequence analysis of GRHL2 gene) Unilabs Genetics CGC Genetics Portugal | 2 | 1 |
|
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 142 | 84 |
|
Deafness, autosomal dominant: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 40 | 39 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Hearing Loss Advanced Sequencing and CNV Evaluation Athena Diagnostics Inc United States | 249 | 184 |
|
Autosomal Dominant Hereditary Hearing Loss/Deafness , Panel Massive Sequencing (NGS) 31 Genes Reference Laboratory Genetics Spain | 31 | 31 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.